Elite Pharmaceuticals, Inc. Restricted Cash
Elite Pharmaceuticals, Inc. (ELTP) had Restricted Cash of $432.83 thousand as of 2024-03-31, per its 10-K filed 2024-07-01.
Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCash · last filed 2024-07-01
- 2024-03-31: Restricted Cash $432.83K.
- 2023-12-31: Restricted Cash $428.00K.
- 2023-09-30: Restricted Cash $422.75K.
- 2023-06-30: Restricted Cash $415.43K.
| Period end | Restricted Cash |
|---|---|
| 2024-03-31 | $432.83K 10-K · filed 2024-07-01 |
| 2023-12-31 | $428.00K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $422.75K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $415.43K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $412.43K 10-K · filed 2024-07-01 |
| 2022-12-31 | $405.16K 10-Q · filed 2023-02-14 |
| 2022-09-30 | $405.16K 10-Q · filed 2022-11-14 |
| 2022-03-31 | $405.04K 10-K · filed 2023-06-29 |